Benzinga | Mar 8, 2021 07:34AM EST

Minerva Neurosciences Q4 EPS $(0.17) Beats $(0.19) Estimate

Minerva Neurosciences (NASDAQ:NERV) reported quarterly losses of $(0.17) per share which beat the analyst consensus estimate of $(0.19) by 10.53 percent. This is a 77.92 percent increase over losses of $(0.77) per share from the same period last year.